Dudediligence.

INmune Bio Inc

INMBNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Director or officer changeSep 14 →InsidersNo open-market buys or sales.→HoldersVanguard 2.6%AQR 2.4%BlackRock 1.1%→Financing →PeersClosest companies: CUE, ROIV, HCWB→

From the filings

Figures

Revenue
$50,000last 12 months
Net income
−$18.4Mlast 12 months
Operating cash flow
−$19.2Mlast 12 months
Cash and equivalents
$18.4Mat the last balance sheet
Shares outstanding
27.7M shareson issue
Every year and quarter →